Antimicrobial peptides (AMPs), which are produced by multicellular organisms as a defense
mechanism against competing pathogenic microbes, appear to be excellent candidates for …

Some mastoparan peptides extracted from social wasps display antimicrobial activity and
some are hemolytic and cytotoxic. Although the cell specificity of these peptides is complex …

The development of bacterial resistant strains is a global health concern. Designing
antibiotics that limit the rise of pathogenic resistance is essential to efficiently treat …

The antimicrobial peptide (AMP) is a class of molecules that are active against a variety of
microorganisms, from bacterial and cancer cells to fungi. Most AMPs are natural products, as …

Antimicrobial Peptides (AMPs) have emerged as promising alternatives to conventional
antibiotics due to their capacity to disrupt the lipid packing of bacterial cell membranes. This …

Naturally occurring membranolytic antimicrobial peptides (AMPs) are rarely cell-type
selective and highly potent at the same time. Template-based peptide design can be used to …

Many potent antimicrobial peptides also present hemolytic activity, an undesired collateral
effect for the therapeutic application. Unlike other mastoparan peptides, Polybia-MP1 …

Antimicrobial peptides (AMPs) kill bacteria by targeting their membranes through various
mechanisms involving peptide assembly, often coupled with disorder‐to‐order structural …

Antimicrobial peptides (AMPs) have gained increasing attention, as they can overcome
recurring microbial invasions. However, their poor antimicrobial activity and potential …

Antimicrobial peptides (AMPs) display promising potential in cancer therapy. Modification
with fatty acids is a simple and effective approach to improve the activity of AMPs. In the …